Study of INBRX-109 in Conventional Chondrosarcoma
Clinical trial NCT04950075 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04950075
- Sponsor
- Inhibrx Biosciences, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2025-09-30
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.